{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:44:11Z","timestamp":1769561051311,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejrad.2016.10.013","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T18:17:37Z","timestamp":1476728257000},"page":"2281-2287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic efficacy and safety of gadoteric acid MR mammography in 1537 patients"],"prefix":"10.1016","volume":"85","author":[{"given":"Tim","family":"Seithe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Vahldiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajana","family":"Wolny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Pociej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Heine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"de Bucourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2016.10.013_bib0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/radiology.165.3.3317495","article-title":"Multiple cerebral metastases: detectability with gd-dtpa-enhanced MR imaging","volume":"3","author":"Russell","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004728-199003000-00010","article-title":"Gadolinium-DOTA enhanced fast imaging of liver tumors at 1.5 T","volume":"2","author":"Marchal","year":"1990","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/radiology.190.2.8284392","article-title":"Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging","volume":"2","author":"Hamm","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0020","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2214\/ajr.174.4.1741127","article-title":"Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography","volume":"4","author":"Ruehm","year":"2000","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ejrad.2011.04.022","article-title":"Tolerability and diagnostic value of gadoteric acid in the general population and in patients with risk factors: results in more than 84,000 patients","volume":"5","author":"Maurer","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.rli.0000209657.16115.42","article-title":"Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use","volume":"6","author":"Knopp","year":"2006","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0028-1109202","article-title":"Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (multihance)","volume":"7","author":"Herborn","year":"2009","journal-title":"Rofo"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.rli.0000248893.01067.e5","article-title":"Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (gd-dota)","volume":"1","author":"Herborn","year":"2007","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0045","unstructured":"Arzneimittelgesetz in der Fassung der Bekanntmachung vom 12. Dezember 2005 (BGBl. I S. 3394), das zuletzt durch Artikel 3 des Gesetzes vom 10. Dezember 2015 (BGBl. I S. 2210) ge\u00e4ndert worden ist, Gesetz \u00fcber den verkehr mit arzneimitteln (arzneimittelgesetz \u2013 AMG). Law on the Marketing of Medicinal Products (Medicines Act \u2013 AMG) Medicines Act: http:\/\/www.gesetze-im-internet.de\/amg_1976\/. Accessed 27.03.16 (2016)."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0050","series-title":"Obesity: Preventing and Managing the Global Epidemic, Report of a WHO Consultation. WHO Technical Report Series","first-page":"253","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0055","series-title":"BMI Classification","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004424-199502000-00002","article-title":"Safety and efficacy of dotarem (gd-dota) versus magnevist (gd-dtpa) in magnetic resonance imaging of the central nervous system","volume":"2","author":"Oudkerk","year":"1995","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s003300050800","article-title":"MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease","volume":"6","author":"Rieber","year":"1999","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0029-1246072","article-title":"Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy","volume":"5","author":"Baltzer","year":"2011","journal-title":"Rofo"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1148\/radiol.13120121","article-title":"Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density","volume":"3","author":"Scaranelo","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1148\/radiol.14140645","article-title":"Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging","volume":"2","author":"Strobel","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1148\/radiol.14131893","article-title":"Breast MR imaging screening in women with a history of breast conservation therapy","volume":"2","author":"Gweon","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1148\/rg.335125185","article-title":"Patterns of nonmasslike enhancement at screening breast MR imaging of high-risk premenopausal women","volume":"5","author":"Giess","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1258\/ar.2012.110477","article-title":"Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy","volume":"4","author":"Stivalet","year":"2012","journal-title":"Acta Radiol."},{"key":"10.1016\/j.ejrad.2016.10.013_bib0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1148\/radiol.11110091","article-title":"Screening breast MR imaging in women with a history of lobular carcinoma in situ","volume":"2","author":"Sung","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1148\/radiology.196.2.7617858","article-title":"Clinical safety of gadopentetate dimeglumine","volume":"2","author":"Nelson","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1148\/radiol.12112025","article-title":"Immediate hypersensitivity reaction to gadolinium-based MR contrast media","volume":"2","author":"Jung","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"1","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0120","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced t1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"3","author":"Kanda","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1148\/radiol.14140364","article-title":"High signal intensity in dentate nucleus on unenhanced t1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration","volume":"3","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"3","author":"McDonald","year":"2015","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejrad.2016.10.013_bib0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cmmi.1683","article-title":"High signal intensity in dentate nucleus and globus pallidus on unenhanced t1-weighted MR images in three patients with impaired renal function and vascular calcification","volume":"11","author":"Barbieri","year":"2016","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2015150872","article-title":"High signal intensity in globus pallidus and dentate nucleus on unenhanced t1-weighted MR images: evaluation of two linear gadolinium-based contrast agents","volume":"3","author":"Ramalho","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"3","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.013_bib0150","series-title":"FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI)","author":"US Food and Drug Administration","year":"2016"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16303187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16303187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T14:25:14Z","timestamp":1536330314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X16303187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0720048X16303187"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.013","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic efficacy and safety of gadoteric acid MR mammography in 1537 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}